Published online 9 February 2004. doi:10.1083/jcb.200308155
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 164, Number 4, 613-623
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects
Lukas Kenner1,
Astrid Hoebertz1,
Timo Beil2,
Niamh Keon3,
Florian Karreth1,
Robert Eferl1,
Harald Scheuch1,
Agnieszka Szremska1,
Michael Amling2,
Marina Schorpp-Kistner3,
Peter Angel3, and
Erwin F. Wagner1
1 Research Institute of Molecular Pathology (IMP), A-1030 Vienna, Austria
2 Department of Trauma, Hand, and Reconstructive Surgery, Hamburg University School of Medicine, D-20246 Hamburg, Germany
3 Department of Signal Transduction and Growth Control, Deutsches Krebsforschungszentrum (DKFZ), D-69120 Heidelberg, Germany
Address correspondence to Erwin F. Wagner, Research Institute of Molecular Pathology, Dr. Bohr-Gasse 7, A-1030 Vienna, Austria. Tel.: 43-1-797-30-888. Fax: 43-1-798-71-53. email: wagner{at}imp.univie.ac.at
Because JunB is an essential gene for placentation, it was conditionally deleted in the embryo proper. JunB
/
mice are born viable, but develop severe low turnover osteopenia caused by apparent cell-autonomous osteoblast and osteoclast defects before a chronic myeloid leukemia-like disease. Although JunB was reported to be a negative regulator of cell proliferation, junB
/
osteoclast precursors and osteoblasts show reduced proliferation along with a differentiation defect in vivo and in vitro. Mutant osteoblasts express elevated p16INK4a levels, but exhibit decreased cyclin D1 and cyclin A expression. Runx2 is transiently increased during osteoblast differentiation in vitro, whereas mature osteoblast markers such as osteocalcin and bone sialoprotein are strongly reduced. To support a cell-autonomous function of JunB in osteoclasts, junB was inactivated specifically in the macrophageosteoclast lineage. Mutant mice develop an osteopetrosis-like phenotype with increased bone mass and reduced numbers of osteoclasts. Thus, these data reveal a novel function of JunB as a positive regulator controlling primarily osteoblast as well as osteoclast activity.
Key Words: AP-1; conditional gene targeting; osteoblasts; osteopenia; osteopetrosis
L. Kenner and A. Hoebertz contributed equally to this paper.
Abbreviations used in this paper: AP-1, activator protein-1; CML, chronic myeloid leukemia; ES, embryonic stem; M-CSF, macrophage colonystimulating factor; MMP-9, matrix metalloproteinase-9; RANKL, receptor activator of NF
B ligand; TRAP, tartrate-resistant acid phosphatase.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
Boning up on JunB
- Alan W. Dove
J. Cell Biol. 2004 164: 477.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Rangaswami, H., Marathe, N., Zhuang, S., Chen, Y., Yeh, J.-C., Frangos, J. A., Boss, G. R., Pilz, R. B.
(2009). Type II cGMP-dependent Protein Kinase Mediates Osteoblast Mechanotransduction. J. Biol. Chem.
284: 14796-14808
[Abstract]
[Full Text]
-
Wu, J. Y., Purton, L. E., Rodda, S. J., Chen, M., Weinstein, L. S., McMahon, A. P., Scadden, D. T., Kronenberg, H. M.
(2008). Osteoblastic regulation of B lymphopoiesis is mediated by Gs{alpha}-dependent signaling pathways. Proc. Natl. Acad. Sci. USA
105: 16976-16981
[Abstract]
[Full Text]
-
Textor, B., Licht, A. H., Tuckermann, J. P., Jessberger, R., Razin, E., Angel, P., Schorpp-Kistner, M., Hartenstein, B.
(2007). JunB Is Required for IgE-Mediated Degranulation and Cytokine Release of Mast Cells. J. Immunol.
179: 6873-6880
[Abstract]
[Full Text]
-
Staber, P. B., Vesely, P., Haq, N., Ott, R. G., Funato, K., Bambach, I., Fuchs, C., Schauer, S., Linkesch, W., Hrzenjak, A., Dirks, W. G., Sexl, V., Bergler, H., Kadin, M. E., Sternberg, D. W., Kenner, L., Hoefler, G.
(2007). The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. Blood
110: 3374-3383
[Abstract]
[Full Text]
-
Karsenty, G.
(2007). Update on the Transcriptional Control of Osteoblast Differentiation. IBMS BoneKEy
4: 164-170
[Abstract]
[Full Text]
-
Licht, A. H., Pein, O. T., Florin, L., Hartenstein, B., Reuter, H., Arnold, B., Lichter, P., Angel, P., Schorpp-Kistner, M.
(2006). JunB is required for endothelial cell morphogenesis by regulating core-binding factor {beta}. JCB
175: 981-991
[Abstract]
[Full Text]
-
Nausch, N., Florin, L., Hartenstein, B., Angel, P., Schorpp-Kistner, M., Cerwenka, A.
(2006). Cutting Edge: The AP-1 Subunit JunB Determines NK Cell-Mediated Target Cell Killing by Regulation of the NKG2D-Ligand RAE-1{epsilon}. J. Immunol.
176: 7-11
[Abstract]
[Full Text]
-
St-Arnaud, R.
(2005). Ubiquitin Ligase: What Is Your True Substrate?. IBMS BoneKEy
2: 6-10
[Full Text]
-
Naito, J., Kaji, H., Sowa, H., Hendy, G. N., Sugimoto, T., Chihara, K.
(2005). Menin Suppresses Osteoblast Differentiation by Antagonizing the AP-1 Factor, JunD. J. Biol. Chem.
280: 4785-4791
[Abstract]
[Full Text]
-
Hess, J., Angel, P., Schorpp-Kistner, M.
(2004). AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci.
117: 5965-5973
[Abstract]
[Full Text]
-
Karreth, F., Hoebertz, A., Scheuch, H., Eferl, R., Wagner, E. F.
(2004). The AP1 transcription factor Fra2 is required for efficient cartilage development. Development
131: 5717-5725
[Abstract]
[Full Text]
-
Narayanan, K., Srinivas, R., Peterson, M. C., Ramachandran, A., Hao, J., Thimmapaya, B., Scherer, P. E., George, A.
(2004). Transcriptional Regulation of Dentin Matrix Protein 1 by JunB and p300 during Osteoblast Differentiation. J. Biol. Chem.
279: 44294-44302
[Abstract]
[Full Text]